A world-class team of scientists and drug developers
Our experienced and proven team combines experts in drug and medical countermeasure development and regulatory strategy with world-leading scientists in the chemistry and biochemistry of heavy metals and radioisotopes, making us uniquely positioned to successfully deliver our first and potentially class-leading drug candidate to the market.
Team
Julian Rees, PhD
CEO and Co-Founder
Rebecca Abergel, PhD
CSO and Co-Founder
Hannah Weber, MBA, MPH
Vice President, Strategy & Business Development and Co-Founder
Jody Khouri, PMP, CA-AM
Vice President, Program, Portfolio, & Alliance Management
Michelle Rose, PhD
Head of Regulatory
Mark Sorenson, PhD
Head of CMC Development
Lawrence Trost, PhD, DABT
Head of Toxicology
Sulin Shah, JD
General Counsel
Laura Vega, PMP, EVP
Director, FP&A / Program Contract Financial Management
Josh Godshaw, PMP
Associate Director, Quantitative Science
TJ Yokley, PhD
Scientist, Discovery Research
Ariana Robertson
Project Coordinator
Daniel Mulugeta
Senior Research Associate
Sharlene Tingin
Executive Assistant / Office Lead
Madison Pearson
Research Associate
Dmitry Zamoryakhin, MD, MBA
Clinical Development Consultant
Michelle Woods
Quality Assurance Consultant
JP Clement, MD
Pharmacovigilance Consultant
Jennifer True
Pharmacovigilance Operations ConsultantAdvisors
Clifford Samuel
Dan Hanfling, MD
